As shown in Figure 4c,d, the survival rate for patients with tumor-expressing membranous EGFR was nonsignificantly higher than those who were expressing cytoplasmic EGFR in EGFRWT and EGFRM cases (p = 0.086 and 0.181, respectively). The gene discussed is EGFR; the disease is neoplasm.